HSPB1 (Ab-15) Antibody

Shipped with Ice Packs
In Stock

Description

Recommended Applications and Dilutions

The HSPB1 (Ab-15) Antibody has been validated for use in multiple experimental techniques with specific recommended dilutions to ensure optimal performance . Proper dilution is critical for obtaining specific signal with minimal background.

Table 2: Recommended Applications and Dilutions

TechniqueRecommended Dilution
Immunohistochemistry (IHC) on formalin-fixed, paraffin-embedded sections1:50-1:100
Western Blot (WB)1:500-1:1000

HSPB1 Protein: Structure and Function

Understanding the target protein is essential for effective utilization of the HSPB1 (Ab-15) Antibody. HSPB1 is a ubiquitously expressed molecular chaperone belonging to the small heat shock protein family . It plays critical roles in cellular stress response and protein quality control mechanisms.

Molecular Structure

HSPB1 contains an alpha-crystallin domain (ACD) that is characteristic of small heat shock proteins . The protein forms dynamic oligomeric structures that can change in response to cellular conditions and post-translational modifications. Under normal physiological conditions, HSPB1 forms large oligomeric assemblies that can dissociate into smaller oligomers upon stress or phosphorylation .

Research utilizing structural analysis has revealed that disease-causing mutations in HSPB1 can significantly alter its quaternary structure. Particularly, mutations such as R127W, S135F, and R136W induce dramatic changes to the quaternary structure despite minimal effects on thermal stability . At high concentrations or under molecular crowding conditions, these mutant forms create assemblies approximately twice the size of wild-type HSPB1 structures .

Functional Roles

HSPB1 serves multiple functions within cells, including:

  1. Protein folding assistance and prevention of protein aggregation

  2. Regulation of cellular stress response

  3. Modulation of inflammatory processes

  4. Participation in autophagy pathways

Recent research has demonstrated that HSPB1 is necessary for autophagosome formation, a critical step in the autophagy process . Wild-type HSPB1 interacts with the autophagy receptor SQSTM1/p62 through the latter's PB1 domain, facilitating the formation of SQSTM1/p62 bodies that are essential for phagophore formation .

Additionally, HSPB1 can be secreted from astrocytes to mediate non-cell-autonomous protective functions in the central nervous system . Extracellular HSPB1 has been shown to dampen inflammatory responses in astrocyte cultures and ex vivo models, suggesting a broader role in neuroprotection .

Applications of HSPB1 (Ab-15) Antibody in Research

The HSPB1 (Ab-15) Antibody serves as a valuable tool for investigating HSPB1 expression, localization, and function across various experimental contexts.

Immunohistochemistry Applications

In immunohistochemistry, the HSPB1 (Ab-15) Antibody enables visualization of HSPB1 protein expression patterns in formalin-fixed, paraffin-embedded tissue sections . This application is particularly valuable for examining HSPB1 expression in neural tissues affected by neurodegenerative disorders such as Charcot-Marie-Tooth disease.

When used at the recommended dilution of 1:50-1:100, the antibody provides specific staining of HSPB1 in human tissue samples . This specificity allows researchers to examine the distribution and expression levels of HSPB1 in normal versus diseased tissues.

Western Blot Applications

For western blot analysis, the HSPB1 (Ab-15) Antibody enables quantitative assessment of HSPB1 protein levels in tissue or cell lysates . When used at the recommended dilution of 1:500-1:1000, the antibody specifically detects HSPB1 at approximately 27 kDa .

Western blotting applications of this antibody are particularly useful for:

  • Comparing HSPB1 expression levels between different experimental conditions

  • Detecting post-translational modifications of HSPB1

  • Validating knockdown or overexpression of HSPB1 in experimental models

HSPB1 in Disease Pathology

Research utilizing antibodies against HSPB1, including the HSPB1 (Ab-15) Antibody, has significantly advanced our understanding of HSPB1's role in various pathological conditions, particularly neurodegenerative disorders.

HSPB1 and Charcot-Marie-Tooth Disease

Mutations in the HSPB1 gene have been linked to Charcot-Marie-Tooth (CMT) disease, a commonly occurring peripheral neuropathy, and distal hereditary motor neuropathy (dHMN) . CMT disease is characterized by progressive degeneration of the foot, lower leg, hand, and forearm muscles, accompanied by distal sensory loss .

Specific autosomal dominant HSPB1 mutations, including R127W, S135F, and R136W, have been extensively studied . These mutations induce significant alterations to HSPB1's quaternary structure, affecting its oligomerization and interactions with partner proteins such as HSPB6 . At low concentrations, mutant HSPB1 proteins show a higher propensity to dissociate into small oligomers, and this dissociation is enhanced by MAPKAP kinase-2 mediated phosphorylation for the R127W and R135F mutants .

HSPB1 and Autophagy Impairment

Recent research has revealed that mutations in HSPB1 lead to impairment of macroautophagy/autophagic flux . Studies utilizing HSPB1 knockout cells have demonstrated that HSPB1 is necessary for autophagosome formation, and this function can be rescued upon re-expression of wild-type HSPB1 .

Wild-type HSPB1 protein binds to the autophagy receptor SQSTM1/p62, with the PB1 domain of SQSTM1 being essential for this interaction . Mutations in HSPB1 decrease the formation of SQSTM1/p62 bodies and subsequently impair phagophore formation, suggesting a regulatory role for HSPB1 in autophagy via interaction with SQSTM1 .

Notably, these autophagy deficits have been confirmed in patient-derived motor neurons, indicating that autophagy impairment might be one of the pathomechanisms by which mutations in HSPB1 lead to peripheral neuropathy .

HSPB1 in Neuroinflammation and Neuroprotection

Recent findings indicate that HSPB1 is secreted from astrocytes and exerts non-cell-autonomous protective functions . Extracellular HSPB1 has been shown to dampen inflammatory responses in astrocyte cultures and ex vivo models .

In primary mouse astrocytes, treatment with recombinant human HSPB1 (rhHSPB1) ameliorates reactive inflammatory responses, as evidenced by reduced markers of astrocyte reactivity and decreased secretion of mediators of neurotoxicity and inflammation such as LCN2 . Similar effects have been observed in organotypic brain slices, where the presence of HSPB1 in the extracellular environment diminishes the inflammatory reaction in astrocytes .

Furthermore, increased expression of human HSPB1 in astrocytes or treatment with recombinant HSPB1 can reduce the accumulation of aggregated tau in brain slice models, suggesting a potential role in mitigating tauopathies .

Research Methodologies Using HSPB1 (Ab-15) Antibody

The HSPB1 (Ab-15) Antibody can be incorporated into various experimental protocols to investigate HSPB1's expression, localization, and function.

Protein Expression Analysis

For quantitative assessment of HSPB1 protein levels, western blot analysis utilizing the HSPB1 (Ab-15) Antibody at a dilution of 1:500-1:1000 is recommended . This approach allows researchers to:

  1. Compare HSPB1 expression levels between different experimental conditions

  2. Assess the impact of gene knockdown or overexpression on HSPB1 protein levels

  3. Evaluate the effects of various treatments on HSPB1 expression

Tissue Localization Studies

Immunohistochemistry on formalin-fixed, paraffin-embedded tissue sections using the HSPB1 (Ab-15) Antibody at a dilution of 1:50-1:100 enables visualization of HSPB1 distribution in tissues . This approach is particularly valuable for:

  1. Examining HSPB1 expression patterns in normal versus diseased tissues

  2. Investigating cell-type specific expression of HSPB1

  3. Correlating HSPB1 localization with pathological features

Best Practices for Using HSPB1 (Ab-15) Antibody

To ensure optimal results when working with the HSPB1 (Ab-15) Antibody, researchers should adhere to the following best practices:

Optimization of Experimental Conditions

While recommended dilutions for various applications are provided (1:50-1:100 for immunohistochemistry and 1:500-1:1000 for western blot) , researchers may need to optimize these dilutions based on their specific experimental conditions, sample types, and detection systems.

For western blot applications, optimization of blocking conditions, incubation times, and washing steps may be necessary to minimize background and maximize specific signal. Similarly, for immunohistochemistry, optimization of antigen retrieval methods, blocking conditions, and detection systems may enhance staining specificity and intensity.

Product Specs

Form
Supplied at a concentration of 1.0mg/mL in phosphate buffered saline (PBS) without magnesium (Mg2+) and calcium (Ca2+), pH 7.4. The solution also contains 150mM sodium chloride (NaCl), 0.02% sodium azide, and 50% glycerol.
Lead Time
We typically ship products within 1-3 business days of receiving your order. The delivery time may vary depending on the purchasing method or location. Please consult your local distributor for specific delivery time information.
Synonyms
Heat shock 27kDa protein antibody; 28 kDa heat shock protein antibody; CMT2F antibody; DKFZp586P1322 antibody; epididymis secretory protein Li 102 antibody; Estrogen regulated 24 kDa protein antibody; Estrogen-regulated 24 kDa protein antibody; Heat shock 25kDa protein 1 antibody; Heat shock 27 kDa protein antibody; Heat shock 27kD protein 1 antibody; Heat shock 27kDa protein 1 antibody; Heat shock 28kDa protein 1 antibody; Heat Shock Protein 27 antibody; Heat shock protein beta 1 antibody; Heat shock protein beta-1 antibody; heat shock protein family B (small) member 1 antibody; HEL-S-102 antibody; HMN2B antibody; HS.76067 antibody; Hsp 25 antibody; HSP 27 antibody; Hsp 28 antibody; Hsp B1 antibody; Hsp25 antibody; HSP27 antibody; Hsp28 antibody; HspB1 antibody; HSPB1_HUMAN antibody; SRP27 antibody; Stress responsive protein 27 antibody; Stress-responsive protein 27 antibody
Target Names
Uniprot No.

Target Background

Function
HSPB1, a small heat shock protein, functions as a molecular chaperone. Its primary role is to maintain denatured proteins in a folding-competent state, preventing aggregation. This chaperone activity contributes to stress resistance and the organization of actin filaments. Through its molecular chaperone function, HSPB1 likely regulates various biological processes, including the phosphorylation and axonal transport of neurofilament proteins.
Gene References Into Functions
  1. Research suggests that both HSPB1/Hsp27 and the constitutive chaperone Hsc70/HspA8 interact with tau to prevent tau-fibril/amyloid formation. HSPB1 delays tau-fibril formation by weakly interacting with early species in the aggregation process. (HspB1 = heat shock protein family B small member 1; Hsc70 = heat shock protein family A Hsp70) PMID: 29298892
  2. HSP27 is a partner of JAK2-STAT5 and a potential therapeutic target in myelofibrosis. PMID: 29650953
  3. Studies show that HSP27 expression is significantly increased in metastatic prostate cancer and represents a strong marker predicting survival, along with ALDH6A1 and prohibitin. PMID: 30396985
  4. High HSP27 expression has been associated with breast cancer. PMID: 30106436
  5. Our data suggest that overexpression of peroxiredoxin-2, annexin A2, and heat shock protein beta-1 was correlated with tumor invasion, metastasis, and poor prognosis, indicating these proteins as potential diagnostic and therapeutic biomarkers. PMID: 29332450
  6. ETAS down-regulated HSP27 and pHSP27 (serine 78) in KLM1-R cells, while HSP70 and GRP78 levels were not altered. This study suggests the potential therapeutic benefit of ETAS in enhancing anticancer effects by its combination with gemcitabine for patients with pancreatic cancer. PMID: 29936456
  7. Silencing of HSP27 increases curcumin resistance by reducing apoptosis and reactive oxidative stress production in colon cancer. PMID: 30056019
  8. The expression of type I and III collagen in the TGF-beta1-induced transition of A549 cells to myofibroblasts was significantly downregulated by transfection of A549 cells with HSP27 plasmid Dinterfering sequence and optimal ratio of Lipofectamine(R) 2000 and HSP27 plasmid. PMID: 29568951
  9. It was suggested that the HSP27 expression in EUS-FNA samples was useful for predicting GEM sensitivity. PMID: 29695571
  10. High hsp27 expression is associated with leukemia. PMID: 29328466
  11. p-Hsp27 is a novel biomarker of glioma and might have important clinical value for further classification of patients with wild-type IDH1 and normal ATRX expression and for evaluating prognosis. PMID: 29550762
  12. Dimer-monomer equilibrium of human HSP27 is influenced by the in-cell macromolecular crowding environment and is controlled by fatty acids and heat. PMID: 29635040
  13. HSP27 expression promotes vascular smooth muscle cell viability, suppresses cell apoptosis, and confers protection against oxidative stress in Thoracic aortic dissection. PMID: 29209372
  14. Hsp27 and P38MAPK could be used as prognostic factors in Esophageal squamous cell carcinoma. PMID: 29099815
  15. Addition of apatorsen to chemotherapy does not improve outcomes in unselected patients with metastatic pancreatic cancer in the first-line setting, although a trend toward prolonged PFS and OS in patients with high baseline serum Hsp27 suggests this therapy may warrant further evaluation in this subgroup. PMID: 28935773
  16. High HSP27 expression is associated with non-small cell lung cancer metastasis. PMID: 28656293
  17. Knockdown of HSP27 blocked TGF-beta-induced cisplatin resistance. PMID: 28848138
  18. The expression of HSP27 was approximately 2-fold higher in apical periodontitis. Next, an increased expression of HSP27 was detected in epithelial cells. PMID: 28673495
  19. Findings indicate the heat-shock protein 27 (Hsp27) pathway as a therapeutic target for the management of conditions featuring dysregulated interleukin 1 beta (IL-1beta) production. PMID: 27976724
  20. Increased protein level of HSP27 through SUMO2/3-mediated SUMOylation plays crucial roles in the progression of primary hepatocellular carcinoma. PMID: 28665748
  21. When the correlations of the markers with the response to neoadjuvant chemotherapy were examined, only high pre-chemotherapy levels of cytoplasmic HSPB1/p correlated with a poor clinical and pathological response to neoadjuvant cisplatin chemotherapy (p = 0.056), suggesting that this marker could be useful for further investigation in a larger number of cases. PMID: 28608263
  22. Exposure to cetuximab and various concentrations of AG490, an inhibitor of JAK2, STAT3 and HSP27 protein levels, except in the KRAS G12V mutant line, SW620...cetuximab may promote SN38 sensitivity via suppression of HSP27, through blocking the JAK/STAT signaling pathway, and shows synergistic effects when combined with SN38 in wild-type RAS CRC cells. PMID: 28656305
  23. We concluded that HSP27-silenced placenta-derived multipotent cells differentiated into neurons possessing the characteristics of functional glutamatergic neurons. PMID: 27444754
  24. Data show that Hsp27 increases the degradation rate of ubiquitinated MST1 and therefore interrupts the Hippo pathway kinase cascade. Consequently, YAP and TAZ are less phosphorylated, free to translocate into the nucleus, promoting a malignant phenotype. These findings underscore the central importance of Hsp27 in regulating multiple signaling pathways that promote tumor aggressiveness. PMID: 27555231
  25. Upregulation of Hsp27 is a common phenomenon shared between pregnancies in patients with preterm prelabor rupture of membranes and spontaneous preterm labor with intact membranes. PMID: 28497897
  26. HSP27 is an independent predictor of prognosis in chronic HF. PMID: 28844461
  27. Hsp27 may up-regulate the expression of ABCA1 and promotes cholesterol efflux through activation of the PI3K/PKCzeta/Sp1 signal pathway in THP-1 macrophage-derived foam cells. PMID: 28610841
  28. This study reports solution-state nuclear magnetic resonance spectroscopy investigations of the conformation and dynamics of the disordered and flexible C-terminal region of human HSP27. These data indicate a potential role for cis-trans proline isomerization in regulating the oligomerization. PMID: 28547731
  29. Overexpression of both HSPB5 and Hsp27 significantly reduced the intracellular aggregation of alpha-synuclein. PMID: 28337642
  30. HspB1 structural organization displays dynamic and complex rearrangements in response to changes in the cellular environment or when the cell physiology is modified. [review] PMID: 28144778
  31. Glutathione-S-transferase - HspB1 fusion protein prevents more aggregation of malate dehydrogenase compared to glutathione-S-transferase -HspB5 fusion protein and wild type HspB1. PMID: 28130664
  32. The data suggest that oncogene-addicted cells require the small heat-shock protein of 27 kDa (HSP27) for survival and that HSP27 might interfere with the effectiveness of targeted agents. PMID: 28182330
  33. Data indicate six cytostatic drugs which inhibit heat shock 27 kDa protein (HSP27) and tackle drug resistance by computational drug repositioning approach. PMID: 27626687
  34. Different from C-M-T phenotype in hereditary neuropathies caused by mutations in the HSPB1 gene. PMID: 27816334
  35. Found that knockdown of HSPB1 further increased the proportion of apoptotic cells in hyperthermic treated melanoma cells when compared with either single agent alone, and both agents led to cell cycle arrest at G0/G1 or G2/M phases. PMID: 27626679
  36. Data suggest that altered dimerization of HSP27 represents a good strategy for anticancer therapy in HSP27-overexpressing cancer cells. PMID: 27449291
  37. Apatorsen ( 2'-methoxyethyl-modified antisense oligonucleotide that inhibits Hsp27 expression) was tolerated at the highest dose evaluated (1000 mg). Single-agent activity was suggested by changes in tumor markers, circulating tumor cells, and stable measurable disease. PMID: 27022067
  38. These results show the central role of Hsp27 in RACK1 pseudosubstrate or LPS-induced cell activation of primary leukocytes. PMID: 27178349
  39. High p-Hsp27 expression is associated with cisplatin resistance in lung cancer. PMID: 26872057
  40. Low p-Hsp27 expression is associated with pancreatic cancer. PMID: 26895107
  41. The up-regulation of Hsp27 by E2 is mediated by ERalpha/Sp1. PMID: 27179757
  42. Study report a novel interaction between mutant HSPB1-P182L and the RNA binding protein PCBP1, leading to a reduction in its translational repression activity. Identifying PCBP1 mRNA targets revealed a marked prevalence for an RNA recognition motif, preferably seen in their 5' and 3'UTRs. Findings further support a role for mutant HSPB1 in neurodegenerative diseases. PMID: 28077174
  43. Hsp 70 and Hsp 27 were expressed in middle ear effusions. PMID: 28964286
  44. High Hsp27 expression is associated with Thyroid Tumors. PMID: 26970173
  45. Bradykinin stimulates myofibroblast migration through protein kinase D-mediated activation of COX-2 and Hsp27. PMID: 28032559
  46. Data suggest that HSPB6 forms hetero-oligomers with HSPB1 under the following rules: (1) highly conserved motif RLFDQXFG is necessary for subunit exchange among oligomers, (2) a site about 20 residues downstream of this motif determines size of resultant hetero-oligomers, and (3) a region in the N-terminal domain that is unique to HSPB6 dictates preferential formation of heterodimers. (HSP = heat shock protein) PMID: 28487364
  47. TNF-alpha stimulates colonic myofibroblast migration through P38 MAPK-mediated activation of COX-2 and Hsp27. PMID: 27451881
  48. The potency of the sHsps to suppress aggregation of model substrates is correlated with their ability to form stable substrate complexes; especially HspB1 and HspB5, but also B3, bind tightly to a variety of proteins. PMID: 27909051
  49. This work examines the molecular mechanism by which two canonical sHsps, alphaB-crystallin (alphaB-c) and Hsp27, interact with aggregation-prone alpha-syn to prevent its aggregation in vitro. Both sHsps are very effective inhibitors of alpha-syn aggregation. PMID: 27587396
  50. This study highlights a novel relation between serum pHSP27 and BMD in Indian women; however, these findings need to be confirmed in larger studies. PMID: 27241641

Show More

Hide All

Database Links

HGNC: 5246

OMIM: 602195

KEGG: hsa:3315

STRING: 9606.ENSP00000248553

UniGene: Hs.520973

Involvement In Disease
Charcot-Marie-Tooth disease 2F (CMT2F); Neuronopathy, distal hereditary motor, 2B (HMN2B)
Protein Families
Small heat shock protein (HSP20) family
Subcellular Location
Cytoplasm. Nucleus. Cytoplasm, cytoskeleton, spindle.
Tissue Specificity
Detected in all tissues tested: skeletal muscle, heart, aorta, large intestine, small intestine, stomach, esophagus, bladder, adrenal gland, thyroid, pancreas, testis, adipose tissue, kidney, liver, spleen, cerebral cortex, blood serum and cerebrospinal f

Q&A

Basic Research Questions

  • What is HSPB1 and why is its phosphorylation at Serine 15 significant?

HSPB1, also known as HSP27, is a member of the small heat shock protein (HSP20) family with a molecular weight of 22.8 kDa and 205 amino acid residues in humans. It primarily localizes to the nucleus and cytoplasm and is widely expressed across various tissue types. HSPB1 plays critical roles in intracellular signal transduction and the regulation of apoptosis, functioning as a molecular chaperone under stress conditions .

Phosphorylation at Serine 15 (S15) represents one of the key post-translational modifications that regulate HSPB1 function. This specific phosphorylation event is particularly important in cellular responses to mechanical stimulation. Research demonstrates that phosphorylation of HSPB1 is required for normal cell behaviors including actin cytoskeletal remodeling, cell spreading, and cell migration . The ability to specifically detect this phosphorylation state using the Ab-15 antibody enables precise investigation of mechanotransduction pathways.

Mechanistically, HSPB1 phosphorylation alters its oligomerization state and interaction with cellular components, particularly the actin cytoskeleton. When phosphorylated at S15, HSPB1 shifts from larger to smaller oligomers, changing its binding properties and cellular functions .

  • What experimental applications is the HSPB1 (Ab-15) Antibody validated for?

The HSPB1 (Ab-15) Antibody has been validated for multiple experimental applications in research settings. Based on available data, the following applications have been confirmed:

ApplicationRecommended DilutionSample TypesExpected Results
Western Blotting1:1000Cell/tissue lysates~23 kDa band
Immunohistochemistry (IHC)1:250FFPE tissue sectionsCellular localization
Immunoprecipitation (IP)As per manufacturerCell lysatesProtein complex isolation

The antibody demonstrates reactivity against human, mouse, and rat phospho-HSPB1, making it versatile for comparative studies across these species . This cross-species reactivity is particularly valuable for translational research comparing model organisms with human samples.

For Western blotting applications, the antibody typically detects a single band at approximately 23 kDa, corresponding to phosphorylated HSPB1. In IHC applications, it enables visualization of phospho-HSPB1 distribution within tissues and cellular compartments, with particularly strong signals observed in tissues under stress conditions or mechanical stimulation .

  • How should samples be prepared to preserve HSPB1 phosphorylation status?

Preserving the phosphorylation status of HSPB1 is critical for accurate experimental results with the Ab-15 antibody. Phosphorylation states can be highly labile, and improper sample handling may lead to artifactual dephosphorylation. Consider the following methodological approach:

Cell/Tissue Lysis Protocol:

  • Pre-chill all buffers and equipment to 4°C

  • Include phosphatase inhibitors in lysis buffer: sodium fluoride (50 mM), sodium orthovanadate (1 mM), β-glycerophosphate (10 mM), and phosphatase inhibitor cocktail

  • Use a buffer composition of PBS with 0.02% sodium azide, 50% glycerol, pH 7.3, supplemented with protease inhibitors

  • Process samples quickly at 4°C

  • For adherent cells, consider direct lysis on plate after quick washing with ice-cold PBS containing phosphatase inhibitors

Sample Storage:

  • Snap-freeze tissues/cells in liquid nitrogen immediately after collection

  • Store samples at -80°C

  • Avoid repeated freeze-thaw cycles

  • For long-term storage, consider adding 50% glycerol to stabilize proteins

These methodological precautions help maintain the phosphorylation state of HSPB1, ensuring accurate detection of the S15 phosphorylated form and reducing false-negative results. The addition of phosphatase inhibitors is particularly crucial as phosphorylation can be rapidly lost during sample preparation.

  • What validation strategies confirm the specificity of HSPB1 (Ab-15) Antibody?

Validating antibody specificity is crucial for generating reliable research data. For phospho-specific antibodies like HSPB1 (Ab-15), implement these methodological approaches:

Phosphatase Treatment Control:

  • Split your sample into two equal portions

  • Treat one portion with lambda phosphatase (400 U/mL) for 30 minutes at 30°C

  • Run both treated and untreated samples on the same gel

  • Probe with the phospho-specific antibody

  • Expect signal loss or significant reduction in the phosphatase-treated sample

Genetic Validation Approaches:

  • Use CRISPR-Cas9 engineered HSPB1-null cells as a negative control

  • Compare antibody reactivity in cells expressing:

    • Wild-type HSPB1

    • S15A (phospho-dead) mutant

    • S15E (phospho-mimetic) mutant

Peptide Competition Assay:

  • Prepare working dilution of antibody

  • Split into two portions

  • Pre-incubate one portion with excess phospho-S15 peptide (100-200 μg/mL)

  • Pre-incubate second portion with non-phosphorylated peptide at same concentration

  • Use both antibody preparations on identical samples

  • Expect signal blocking only with the phospho-peptide

Research has demonstrated that CRISPR-Cas9 engineered HSPB1-null cells provide an excellent negative control for antibody validation . These cells show no reactivity with the antibody, confirming specificity. When these cells are reconstituted with various HSPB1 constructs, only those containing phosphorylatable serine residues show positive signals with phospho-specific antibodies.

Advanced Research Questions

  • What experimental models are optimal for studying HSPB1 phosphorylation dynamics?

Several experimental models have proven effective for investigating HSPB1 phosphorylation dynamics in research settings:

CRISPR-Cas9 Engineered Cell Models:
CRISPR-Cas9 engineered HSPB1-null cells provide a clean genetic background for rescue experiments . This model allows researchers to compare wild-type versus phosphomutant HSPB1 function by reintroducing different HSPB1 variants. Research has shown that only phosphorylatable HSPB1, not phospho-dead mutants, can rescue certain cellular phenotypes in these knockout models .

Mechanical Stimulation Platforms:

  • Substrate stretching systems: Apply controlled cyclic or static stretch to adherent cells and analyze phospho-HSPB1 levels at different time points

  • Micropatterned substrates: Force cells to adopt specific geometries (e.g., 47 μm × 47 μm squares) that create predictable tension patterns

  • Atomic force microscopy (AFM): Apply localized mechanical force and observe real-time phosphorylation responses

Research has established that cells cultured on micropatterned substrates reliably exhibit localization of mechanosensitive proteins like zyxin and HSPB1 to high-tension areas such as cell corners, edges, and actin comet tails, making this an excellent model for studying phospho-HSPB1 dynamics . These geometrically constrained cells create reproducible patterns of mechanical stress that can be systematically analyzed.

The knockout-rescue approach is particularly powerful, as it allows direct comparison of wild-type and mutant HSPB1 functions in an identical cellular background. Studies have demonstrated that wild-type HSPB1, but not non-phosphorylatable HSPB1 mutants, rescues certain characteristics in HSPB1-null cells, including enhanced cell motility and deficient actin reinforcement following stretch stimulation .

  • How can phospho-HSPB1 localization be visualized in relation to cytoskeletal structures?

Visualizing phospho-HSPB1 in relation to cytoskeletal structures requires specialized imaging techniques and careful experimental design:

Multi-color Confocal Microscopy Protocol:

  • Culture cells on appropriate substrates (glass coverslips or micropatterned surfaces)

  • Fix cells with 4% paraformaldehyde (10 minutes, room temperature)

  • Permeabilize with 0.1% Triton X-100 (5 minutes)

  • Block with 3% BSA in PBS (1 hour)

  • Incubate with HSPB1 (Ab-15) antibody at optimized dilution (overnight, 4°C)

  • Add fluorophore-conjugated secondary antibody (1 hour, room temperature)

  • Co-stain for:

    • F-actin (fluorescent phalloidin, 1:200, 30 minutes)

    • Focal adhesions (anti-vinculin or anti-zyxin, 1:200, overnight at 4°C)

    • Nuclei (DAPI, 1:1000, 5 minutes)

  • Mount and image using confocal microscopy

Research findings have demonstrated that phosphorylatable HSPB1 displays mechanoaccumulation to tensed actin stress fibers and is recruited to high-tension structures in geometrically constrained cells, such as actin comet tails emanating from focal adhesions . These observations were made possible through careful co-localization studies with cytoskeletal markers.

For advanced analysis, super-resolution microscopy techniques such as STORM, PALM, or SIM can resolve nanoscale co-localization between phospho-HSPB1 and cytoskeletal elements. Research has used confocal microscopy to localize HSPB1 along with the focal adhesion protein vinculin and F-actin in subcellular contexts, revealing that HSPB1 could be found in linear elements associated with the cytoskeleton .

  • How does mechanical stress regulate HSPB1 phosphorylation, and what experimental setups can capture this phenomenon?

Mechanical stress is a key regulator of HSPB1 phosphorylation, activating specific signaling pathways that modify HSPB1 function. Understanding this regulation requires specialized experimental approaches:

Mechanical Stimulation Methods:

  • Substrate stretching: Using flexible membranes (e.g., silicone) coated with ECM proteins

    • Apply cyclic stretch (5-15%, 0.5-1 Hz) or static stretch (10-20%)

    • Fix cells at different timepoints (5, 15, 30, 60 minutes) after stretch initiation

    • Analyze phospho-HSPB1 levels by western blot or immunofluorescence

  • Micropatterned substrates:

    • Culture cells on substrates with defined geometries (e.g., 47 μm × 47 μm squares)

    • These patterns create predictable areas of high tension at corners and edges

    • Analyze phospho-HSPB1 localization to these high-tension regions

Research has demonstrated that wild-type HSPB1, but not non-phosphorylatable HSPB1 mutants, rescues certain characteristics in HSPB1-null cells following mechanical stimulation, including enhanced cell motility and deficient actin reinforcement . This indicates that phosphorylation is critical for HSPB1's mechanotransduction functions.

The signaling pathway connecting mechanical stimulation to HSPB1 phosphorylation involves activation of the p38 MAPK pathway, leading to MAPKAPK-2 activation, which directly phosphorylates HSPB1 at S15 and other sites. This mechanically activated phosphorylation pathway represents a crucial link between physical forces and cellular biochemical responses.

  • What are the functional consequences of HSPB1 phosphorylation at Serine 15 for cytoskeletal regulation?

HSPB1 phosphorylation at Serine 15 significantly impacts cytoskeletal dynamics and cellular mechanics through several mechanisms:

Actin Cytoskeleton Regulation:

  • Non-phosphorylated HSPB1 binds to actin monomers and caps filament ends, inhibiting polymerization

  • Phosphorylation at S15 reduces binding affinity for actin, promoting filament elongation

  • This phosphorylation-dependent regulation allows for dynamic control of actin remodeling during mechanical stress

Mechanical Force Transduction:

  • Phosphorylation of HSPB1 is required for normal actin reinforcement following mechanical stimulation

  • Only phosphorylatable HSPB1 displays mechanoaccumulation to tensed actin stress fibers

  • The recruitment of HSPB1 to high-tension structures in geometrically constrained cells requires phosphorylatable HSPB1

Research demonstrates that expression of wild-type HSPB1, but not non-phosphorylatable HSPB1, rescued certain characteristics of HSPB1-null cells including enhanced cell motility and deficient actin reinforcement following stretch stimulation . These findings highlight the critical role of HSPB1 phosphorylation in mechanosensitive cellular processes.

In the HSPB1-null cell model, cells exhibit enhanced motility and deficient actin reinforcement in response to mechanical stimulation. Re-expression of wild-type HSPB1 normalizes these behaviors, while non-phosphorylatable HSPB1 mutants fail to restore normal function . This demonstrates that phosphorylation is essential for HSPB1's ability to properly regulate cytoskeletal dynamics under mechanical stress.

  • How can researchers integrate phospho-HSPB1 analysis with functional cellular mechanics studies?

Integrating phospho-HSPB1 analysis with functional cellular mechanics requires multidisciplinary approaches:

Combined Imaging and Mechanical Testing:

  • Traction Force Microscopy (TFM) with simultaneous phospho-HSPB1 imaging:

    • Culture cells on polyacrylamide gels embedded with fluorescent beads

    • Apply mechanical stimulation (stretch or compression)

    • Fix cells at different timepoints

    • Stain for phospho-HSPB1 using Ab-15 antibody

    • Calculate traction forces from bead displacements

    • Correlate force generation with phospho-HSPB1 levels and distribution

  • Live-cell mechanics with phospho-reporters:

    • Transfect cells with FRET-based phospho-sensors

    • Apply mechanical stimulation using AFM or magnetic tweezers

    • Monitor real-time changes in phosphorylation and mechanical properties

Genetic Manipulation Approaches:
Utilizing CRISPR-Cas9 engineered HSPB1-null cells, researchers can perform rescue experiments with various HSPB1 constructs (wild-type, phospho-dead, phospho-mimetic) and measure resulting mechanical phenotypes .

Research has established that phosphorylation of HSPB1 is critical for normal cell behaviors including actin remodeling following stretch stimulation, cell spreading, and cell motility . Only phosphorylatable HSPB1, which displayed mechanoaccumulation to tensed actin stress fibers, restored these activities in HSPB1-null cells.

The relationship between HSPB1 phosphorylation and mechanical properties is bidirectional - mechanical stimulation induces HSPB1 phosphorylation, which in turn alters cell mechanical properties by regulating cytoskeletal organization. This feedback loop is essential for adaptive cellular responses to mechanical environments.

  • What advanced techniques can assess the dynamics of HSPB1 phosphorylation in response to mechanical stimuli?

Understanding the temporal dynamics of HSPB1 phosphorylation requires specialized techniques:

Temporal Resolution Approaches:

  • Time-course analysis with quantitative Western blotting:

    • Apply mechanical stimulus (stretch, shear, etc.)

    • Harvest cells at precise timepoints (30 seconds, 1, 2, 5, 10, 30, 60 minutes)

    • Perform Western blot with phospho-HSPB1 (Ab-15) antibody

    • Normalize to total HSPB1 levels

    • Plot phosphorylation kinetics

  • Live-cell phosphorylation sensors:

    • Genetically encoded FRET-based sensors for HSPB1 phosphorylation

    • Allows real-time monitoring in living cells

    • Can be combined with mechanical stimulation devices

Spatial-Temporal Integration:
Research has demonstrated that phosphorylatable HSPB1 displays mechanoaccumulation to tensed actin stress fibers in response to mechanical stimulation . This dynamic recruitment can be visualized in real-time using fluorescently tagged HSPB1 constructs and correlation with phospho-specific antibody staining at fixed timepoints.

In studies of mechanically stimulated cells, HSPB1 phosphorylation typically shows rapid induction (within minutes), followed by a more sustained phase lasting up to several hours. This biphasic response suggests different regulatory mechanisms and functional consequences in the immediate versus sustained response to mechanical stimulation.

The dynamics of HSPB1 phosphorylation are spatially regulated within the cell, with preferential phosphorylation occurring at sites of high mechanical stress, such as focal adhesions, stress fiber attachment points, and cell edges experiencing tension . This spatial regulation allows for localized control of cytoskeletal dynamics in response to heterogeneous mechanical environments.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.